Back to today’s briefing

Story perspectives

Shingles Vaccine Linked to Lower Dementia Risk in Seniors

2/20/2026

31 6 Full Breakdown

Summary

Story summary

The recombinant herpes zoster (shingles) vaccine is associated with a lower incidence of dementia in older adults, per a Nature Medicine study.
Additional research, including a nested case-control study from the UK Biobank, supports a protective effect of vaccination against neurodegenerative diseases.
These findings suggest antiviral vaccines could help prevent dementia, underscoring the need for further exploration of long-term benefits.

1 of 1

Story summary

The recombinant herpes zoster (shingles) vaccine is associated with a lower incidence of dementia in older adults, per a Nature Medicine study.
Additional research, including a nested case-control study from the UK Biobank, supports a protective effect of vaccination against neurodegenerative diseases.
These findings suggest antiviral vaccines could help prevent dementia, underscoring the need for further exploration of long-term benefits.